SLC30A3 and colorectal carcinoma: We therefore investigated whether altered expression of this gene, of its functional homolog SLC30A3, and of their functional antagonists the SLC39A family member genes SLC39A8 and SLC39A14 may be related to altered sensitivity to CRC drugs.